EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

P-Glycoprotein as a Therapeutic Target in Hematological Malignancies: A Challenge to Overcome

Pablo Álvarez-Carrasco, Fernanda Morales-Villamil, Carmen Maldonado-Bernal iD

International Journal of Molecular Sciences · 14.05.2025 · 26 (10) · 4701

DOI: 10.3390/ijms26104701 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.05.2025. Verfasst von Pablo Álvarez-Carrasco und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Investigación en Inmunología y Proteómica, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Antineoplastic Agents, ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dirección General de Políticas de Investigación en Salud, Hospital Infantil de México Federico Gómez.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

P-glycoprotein (P-gp), a transmembrane efflux pump encoded by the ABCB1/MDR1 gene, is a major contributor to multidrug resistance in hematological malignancies. These malignancies, arising from hematopoietic precursors at various differentiation stages, can manifest in the bone marrow, circulate in the bloodstream, or infiltrate tissues. P-gp overexpression in malignant cells reduces the efficacy of chemotherapeutic agents by actively expelling them, decreasing intracellular drug concentrations, and promoting multidrug resistance, a significant obstacle to successful treatment. This review examines recent advances in combating P-gp-mediated resistance, including the development of novel P-gp inhibitors, innovative drug delivery systems (e.g., nanoparticle-based delivery), and strategies to modulate P-gp expression or activity. These modulation strategies encompass targeting relevant signaling pathways (e.g., NF-κB, PI3K/Akt) and exploring drug repurposing. While progress has been made, overcoming P-gp-mediated resistance remains crucial for improving patient outcomes. Future research directions should prioritize the development of potent, selective, and safe P-gp inhibitors with minimal off-target effects, alongside exploring synergistic combination therapies with existing chemotherapeutics or novel agents to effectively circumvent multidrug resistance in hematological malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsAntineoplastic AgentsATP Binding Cassette Transporter, Subfamily B, Member 1HumansDrug Resistance, NeoplasmAnimalsDrug Resistance, MultipleSignal TransductionDrug Delivery SystemsMolecular Targeted TherapyATP Binding Cassette Transporter, Subfamily B

Stichwörter der Autor:innen

P-glycoproteinhematological malignanciesmultidrug resistancetherapeutic target

Substanzen

Antineoplastic AgentsATP Binding Cassette Transporter, Subfamily B, Member 1ATP Binding Cassette Transporter, Subfamily B

Autor:innen und Institutionen

  • Laboratorio de Investigación en Inmunología y Proteómica, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
  • Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
  • Facultad de Medicina, Benemérita Universidad de Puebla, Puebla 72000, Mexico.

ORCID-Profile: Carmen Maldonado-Bernal

Förderung

  • Dirección General de Políticas de Investigación en Salud
  • Hospital Infantil de México Federico Gómez

Zitieren

APA

Álvarez-Carrasco, P., Morales-Villamil, F., & Maldonado-Bernal, C. (2025). P-Glycoprotein as a Therapeutic Target in Hematological Malignancies: A Challenge to Overcome. International Journal of Molecular Sciences, 26(10), 4701. https://doi.org/10.3390/ijms26104701

Vancouver

Álvarez-Carrasco P, Morales-Villamil F, Maldonado-Bernal C. P-Glycoprotein as a Therapeutic Target in Hematological Malignancies: A Challenge to Overcome. International Journal of Molecular Sciences. 2025;26(10):4701. doi:10.3390/ijms26104701

BibTeX
@article{lvarezCarrasco2025,
  author = {Álvarez-Carrasco, Pablo and Morales-Villamil, Fernanda and Maldonado-Bernal, Carmen},
  title = {P-Glycoprotein as a Therapeutic Target in Hematological Malignancies: A Challenge to Overcome},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {10},
  pages = {4701},
  doi = {10.3390/ijms26104701}
}
Kostenlos starten →